EyePoint, Inc. (EYPT)

3.06 +0.05 (+1.66%) USD  |  NASDAQ  |  Oct 15, 11:53
More

EyePoint Total Long Term Debt (Quarterly) : 19.81M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 19.81M
March 31, 2026 20.23M
December 31, 2025 20.77M
September 30, 2025 21.30M
June 30, 2025 21.82M
March 31, 2025 22.31M
December 31, 2024 21.86M
September 30, 2024 21.92M
June 30, 2024 22.16M
March 31, 2024 4.624M
December 31, 2023 4.906M
September 30, 2023 5.185M
June 30, 2023 5.455M
March 31, 2023 35.09M
December 31, 2022 35.33M
September 30, 2022 35.56M
June 30, 2022 34.11M
March 31, 2022 30.94M
December 31, 2021 38.60M
September 30, 2021 38.63M
June 30, 2021 38.38M
March 31, 2021 40.46M
December 31, 2020 40.50M
September 30, 2020 53.32M
June 30, 2020 52.96M
Date Value
March 31, 2020 50.57M
December 31, 2019 50.12M
September 30, 2019 49.76M
June 30, 2019 49.40M
March 31, 2019 31.95M
December 31, 2018 17.62M
September 30, 2018 17.46M
June 30, 2018 17.31M
March 31, 2018 12.85M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Ocular Therapeutix, Inc. 76.26M
Eli Lilly & Co. 49.62B
Nuvation Bio, Inc. 408.66M
ANI Pharmaceuticals, Inc. 610.49M
Corcept Therapeutics, Inc. 7.504M